Orexin Receptor Antagonism and Sleep in Stimulant Use Disorder

NCT06444256 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Stimulant Use Disorder

Interventions

DRUG: SUVO
DRUG: TAU

Sponsor

The University of Texas Health Science Center, Houston